Immune Related Adverse Events of the Thyroid – A Narrative Review
Immune checkpoints are small molecules present on the cell surface of T-lymphocytes. They maintain self-tolerance and regulate the amplitude and duration of T-cell responses. Antagonism of immune checkpoints with monoclonal antibodies (immune checkpoint inhibitors) is a rapidly evolving field of ant...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.886930/full |
_version_ | 1811256440028921856 |
---|---|
author | Christopher A. Muir Venessa H. M. Tsang Venessa H. M. Tsang Venessa H. M. Tsang Alexander M. Menzies Alexander M. Menzies Alexander M. Menzies Alexander M. Menzies Roderick J. Clifton-Bligh Roderick J. Clifton-Bligh Roderick J. Clifton-Bligh |
author_facet | Christopher A. Muir Venessa H. M. Tsang Venessa H. M. Tsang Venessa H. M. Tsang Alexander M. Menzies Alexander M. Menzies Alexander M. Menzies Alexander M. Menzies Roderick J. Clifton-Bligh Roderick J. Clifton-Bligh Roderick J. Clifton-Bligh |
author_sort | Christopher A. Muir |
collection | DOAJ |
description | Immune checkpoints are small molecules present on the cell surface of T-lymphocytes. They maintain self-tolerance and regulate the amplitude and duration of T-cell responses. Antagonism of immune checkpoints with monoclonal antibodies (immune checkpoint inhibitors) is a rapidly evolving field of anti-cancer immunotherapy and has become standard of care in management of many cancer subtypes. Immune checkpoint inhibition is an effective cancer treatment but can precipitate immune related adverse events (irAEs). Thyroid dysfunction is the most common endocrine irAE and can occur in up to 40% of treated patients. Both thyrotoxicosis and hypothyroidism occur. The clinical presentation and demographic associations of thyrotoxicosis compared to hypothyroidism suggest unique entities with different etiologies. Thyroid irAEs, particularly overt thyrotoxicosis, are associated with increased immune toxicity in other organ systems, but also with longer progression-free and overall survival. Polygenic risk scores using susceptibility loci associated with autoimmune thyroiditis predict development of checkpoint inhibitor associated irAEs, suggesting potentially shared mechanisms underpinning their development. Our review will provide an up-to-date summary of knowledge in the field of thyroid irAEs. Major focus will be directed toward pathogenesis (including genetic factors shared with autoimmune thyroid disease), demographic associations, clinical presentation and course, treatment, and the relationship with cancer outcomes. |
first_indexed | 2024-04-12T17:41:07Z |
format | Article |
id | doaj.art-1c6cb87d532a44eb838e1804ba9ff5d0 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-04-12T17:41:07Z |
publishDate | 2022-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-1c6cb87d532a44eb838e1804ba9ff5d02022-12-22T03:22:48ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-05-011310.3389/fendo.2022.886930886930Immune Related Adverse Events of the Thyroid – A Narrative ReviewChristopher A. Muir0Venessa H. M. Tsang1Venessa H. M. Tsang2Venessa H. M. Tsang3Alexander M. Menzies4Alexander M. Menzies5Alexander M. Menzies6Alexander M. Menzies7Roderick J. Clifton-Bligh8Roderick J. Clifton-Bligh9Roderick J. Clifton-Bligh10Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCancer Genetics, Kolling Institute of Medical Research, Sydney, NSW, AustraliaDepartment of Endocrinology, Royal North Shore Hospital, Sydney, NSW, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, The University of Sydney, Sydney, NSW, AustraliaDepartment of Medical Oncology, Royal North Shore Hospital, Sydney, NSW, AustraliaDepartment of Medical Oncology, Mater Hospital, Sydney, NSW, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCancer Genetics, Kolling Institute of Medical Research, Sydney, NSW, AustraliaDepartment of Endocrinology, Royal North Shore Hospital, Sydney, NSW, AustraliaImmune checkpoints are small molecules present on the cell surface of T-lymphocytes. They maintain self-tolerance and regulate the amplitude and duration of T-cell responses. Antagonism of immune checkpoints with monoclonal antibodies (immune checkpoint inhibitors) is a rapidly evolving field of anti-cancer immunotherapy and has become standard of care in management of many cancer subtypes. Immune checkpoint inhibition is an effective cancer treatment but can precipitate immune related adverse events (irAEs). Thyroid dysfunction is the most common endocrine irAE and can occur in up to 40% of treated patients. Both thyrotoxicosis and hypothyroidism occur. The clinical presentation and demographic associations of thyrotoxicosis compared to hypothyroidism suggest unique entities with different etiologies. Thyroid irAEs, particularly overt thyrotoxicosis, are associated with increased immune toxicity in other organ systems, but also with longer progression-free and overall survival. Polygenic risk scores using susceptibility loci associated with autoimmune thyroiditis predict development of checkpoint inhibitor associated irAEs, suggesting potentially shared mechanisms underpinning their development. Our review will provide an up-to-date summary of knowledge in the field of thyroid irAEs. Major focus will be directed toward pathogenesis (including genetic factors shared with autoimmune thyroid disease), demographic associations, clinical presentation and course, treatment, and the relationship with cancer outcomes.https://www.frontiersin.org/articles/10.3389/fendo.2022.886930/fullimmune related adverse eventscheckpoint inhibitorthyrotoxicosishypothyroidismthyroid |
spellingShingle | Christopher A. Muir Venessa H. M. Tsang Venessa H. M. Tsang Venessa H. M. Tsang Alexander M. Menzies Alexander M. Menzies Alexander M. Menzies Alexander M. Menzies Roderick J. Clifton-Bligh Roderick J. Clifton-Bligh Roderick J. Clifton-Bligh Immune Related Adverse Events of the Thyroid – A Narrative Review Frontiers in Endocrinology immune related adverse events checkpoint inhibitor thyrotoxicosis hypothyroidism thyroid |
title | Immune Related Adverse Events of the Thyroid – A Narrative Review |
title_full | Immune Related Adverse Events of the Thyroid – A Narrative Review |
title_fullStr | Immune Related Adverse Events of the Thyroid – A Narrative Review |
title_full_unstemmed | Immune Related Adverse Events of the Thyroid – A Narrative Review |
title_short | Immune Related Adverse Events of the Thyroid – A Narrative Review |
title_sort | immune related adverse events of the thyroid a narrative review |
topic | immune related adverse events checkpoint inhibitor thyrotoxicosis hypothyroidism thyroid |
url | https://www.frontiersin.org/articles/10.3389/fendo.2022.886930/full |
work_keys_str_mv | AT christopheramuir immunerelatedadverseeventsofthethyroidanarrativereview AT venessahmtsang immunerelatedadverseeventsofthethyroidanarrativereview AT venessahmtsang immunerelatedadverseeventsofthethyroidanarrativereview AT venessahmtsang immunerelatedadverseeventsofthethyroidanarrativereview AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview AT roderickjcliftonbligh immunerelatedadverseeventsofthethyroidanarrativereview AT roderickjcliftonbligh immunerelatedadverseeventsofthethyroidanarrativereview AT roderickjcliftonbligh immunerelatedadverseeventsofthethyroidanarrativereview |